Specialists

Education:

Undergraduate: University of Antioquia

Specialization: Pontifical Bolivarian University

Member of:

Colombian Society of Ophthalmology

Sandiego Ophthalmology Clinic Academic Committee

Publications he has made:

• Event name ARVO 2010 Annual Meeting. The Future of Eye and Vision Research. May 2 – 6, 2010. Fort Lauderdale, Fl.
  Poster session # 424. Diabetic Retinopathy. Poster Presenter4233. Comparison of 2 doses of Intravitreal Bevacizumab (Avastin) for Proliferative Diabetic Retinopathy: Results from the Pan-American Collaborative Retina Study Group (PACORES) at 24 Months of Follow-upMonday, May 03, 2010, 8:30 AM - 8:45 AM
  Paper session # 220. AMD Clinical Trial. Paper Co-Author1250. Comparison of 2 Doses of Primary Intravitreal Bevacizumab for Subfoveal CNV in AMD: Results From the Pan-American Collaborative Retina Study Group at 24 MonthsMonday, May 03, 2010, 8:30 AM - 8:45 AM.
  
  
• Event name ARVO 2010 Annual Meeting. IX Annual Meeting Pan-American Research Day May 1, 2010. Fort Lauderdale, Fl.
  2010 Annual Meeting: Poster PresenterComparison of 2 doses of Intravitreal Bevacizumab (Avastin) for Proliferative Diabetic Retinopathy: Results from the Pan-American Collaborative Retina Study Group (PACORES) at 24 Months of Follow-upSaturday, May 01, 2010, 3:35 PM - 3:40 PM* Recipient of the 2010 Tyson ARVO Clinical Research Initiative Scholarship Award.
  
  
• Event Name Joint Metting of the 29th PAAO Congress and the 113th AAO Annual Meeting Oct 24-27, 2009 San Franciso, CA
  2009 Joint Meeting: Poster Co-AuthorPO248 - Comparison of 2 Doses of Primary Intravitreal Bevacizumab for Subfoveal CNV in AMD: Results From a Multicenter Study Group at 24 MonthsRoom: South, Hall A10/25/2009: 12:30 PM - 2:00 PM* 2009 Best Poster Award
  2009 Joint Meeting: Poster Co-AuthorPO261 – Primary Bevacizumab IVT for Diffuse Diabetic Macular Edema: Results from a 24-Month Retina Collaborative Study GroupRoom: South, Hall A10/25/2009: 12:30 PM - 2:00 PM
  
  
• Name of the event V International Congress of Ophthalmology Clofan August 5 - 7, 2009 Medellín, Colombia
  Paper Co-Author Bevacizumab Primary IVT for Diffuse Diabetic Macular Edema: Results from a 24-Month Retinal Collaborative Study GroupAugust 07, 2009, 10:30 AM - 10:45 AM
  
  
• Event name ARVO 2009 Annual Meeting. Reducing Disparities in Eye Disease and Treatment. May 3 – 7, 2009 Fort Lauderdale, FL
  Paper session # 250. Diabetic Retinopathy III. Poster Co-Author1680. Comparison of 2 Doses of Primary Intravitreal Bevacizumab for Diffuse Diabetic Macular Edema: Results From the Pan-American Collaborative Retina Study Group at 24 MonthsMonday, May 04, 2009, 3:00 PM - 3:15 PM
  
• Event name The 112th AAO Annual Meeting Subspecialty Day Retina. Nov 7 – 8, 2008 Atlanta – GA• 2008 Joint Meeting: Paper Co-AuthorAvastin in the Management of Diabetic Macular EdemaSection XII: Diabetic Retinopathy08/10/2008: 3:44 PM
  
  

Participation in conferences:

• Project name: Primary Intravitreal Bevacizumab for Diffuse Diabetic
  Macular Edema: The Pan-American Collaborative Retina
  Study Group at 24 Months
  Publication date September 2009
  Title of the Ophthalmology Magazine
  
  
• Project Name Intravitreal Bevacizumab for Subfoveal Choroidal Neovascularization in AMD at 24 Months: The Pan-American Collaborative Retina Study Group
  Acceptance date January 28, 2010 (Submission Ms. No. 2009-1328R2)
  Title of the Ophthalmology Magazine

Other studies he has carried out:

Certified in Essential Coaching